52.14
price up icon4.16%   2.08
after-market 시간 외 거래: 52.55 0.41 +0.79%
loading
전일 마감가:
$50.06
열려 있는:
$50
하루 거래량:
1.23M
Relative Volume:
1.48
시가총액:
$5.24B
수익:
$523.53M
순이익/손실:
$118.02M
주가수익비율:
64.37
EPS:
0.81
순현금흐름:
$124.84M
1주 성능:
+8.15%
1개월 성능:
+14.77%
6개월 성능:
+112.64%
1년 성능:
+103.51%
1일 변동 폭
Value
$49.51
$52.35
1주일 범위
Value
$42.01
$52.35
52주 변동 폭
Value
$20.84
$52.35

코르셉트 테라퓨틱스 Stock (CORT) Company Profile

Name
명칭
Corcept Therapeutics Inc
Name
전화
650.688.8803
Name
주소
149 COMMONWEALTH DRIVE, MENLO PARK
Name
직원
352
Name
트위터
Name
다음 수익 날짜
2024-10-30
Name
최신 SEC 제출 서류
Name
CORT's Discussions on Twitter

코르셉트 테라퓨틱스 Stock (CORT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-11-06 업그레이드 Truist Hold → Buy
2023-04-11 개시 SVB Securities Market Perform
2023-04-04 개시 Piper Sandler Overweight
2023-02-15 다운그레이드 Jefferies Buy → Hold
2022-08-01 다운그레이드 Truist Buy → Hold
2022-07-27 업그레이드 Jefferies Hold → Buy
2022-06-27 재개 Canaccord Genuity Buy
2022-02-02 개시 Canaccord Genuity Buy
2022-01-28 개시 Truist Buy
2020-08-05 다운그레이드 Jefferies Buy → Hold
2019-09-24 개시 Jefferies Buy
2019-09-06 개시 H.C. Wainwright Buy
2019-02-04 다운그레이드 B. Riley FBR Buy → Neutral
2018-08-10 재확인 Stifel Hold
2018-05-31 다운그레이드 Stifel Buy → Hold
2018-03-09 개시 B. Riley FBR, Inc. Buy
2017-08-31 개시 Stifel Buy
2017-02-02 개시 Ladenburg Thalmann Buy
2015-04-21 개시 FBR Capital Outperform
2014-01-13 다운그레이드 Stifel Buy → Hold
2013-08-09 다운그레이드 Janney Buy → Neutral
2013-08-09 다운그레이드 Ladenburg Thalmann Buy → Neutral
2012-02-21 재확인 JMP Securities Mkt Outperform
2010-01-06 업그레이드 Ladenburg Thalmann Neutral → Buy
2008-07-17 개시 Rodman & Renshaw Mkt Outperform
2007-06-21 업그레이드 Punk, Ziegel & Co Mkt Perform → Accumulate
모두보기

코르셉트 테라퓨틱스 주식(CORT)의 최신 뉴스

pulisher
12:45 PM

Here is Why Growth Investors Should Buy Corcept (CORT) Now - Yahoo Finance

12:45 PM
pulisher
12:00 PM

Corcept (CORT) Upgraded to Strong Buy: Here's Why - Yahoo Finance

12:00 PM
pulisher
09:15 AM

Corcept Therapeutics Incorporated (CORT) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance Australia

09:15 AM
pulisher
09:04 AM

Corcept Stock At New High; Will The Upcoming Regulatory And Clinical Trial Catalysts Take It Higher? - RTTNews

09:04 AM
pulisher
05:42 AM

Roman Butler Fullerton & Co. Sells 10,466 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

05:42 AM
pulisher
03:11 AM

Creative Planning Acquires 841 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

03:11 AM
pulisher
Nov 04, 2024

Corcept Therapeutics (NASDAQ:CORT) Reaches New 1-Year HighStill a Buy? - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Corcept Therapeutics stock soars to all-time high of $50.23 By Investing.com - Investing.com Australia

Nov 04, 2024
pulisher
Nov 04, 2024

Corcept Therapeutics stock soars to all-time high of $50.23 - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Wall Street Analysts Believe Corcept (CORT) Could Rally 56.66%: Here's is How to Trade - Yahoo Canada Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Recent Price Trend in Corcept (CORT) is Your Friend, Here's Why - Yahoo Canada Finance

Nov 04, 2024
pulisher
Nov 04, 2024

What is HC Wainwright’s Forecast for CORT FY2024 Earnings? - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

Research Analysts Issue Forecasts for CORT FY2024 Earnings - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

What is HC Wainwright’s Estimate for CORT FY2026 Earnings? - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View - MSN

Nov 02, 2024
pulisher
Nov 02, 2024

Corcept Therapeutics (CORT) Stock Declines Amid Market Activity - GuruFocus.com

Nov 02, 2024
pulisher
Nov 01, 2024

Earnings Estimates Moving Higher for Corcept (CORT): Time to Buy? - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Corcept Therapeutics (NASDAQ:CORT) Stock Price Down 3.2%Here's What Happened - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

FY2026 Earnings Estimate for CORT Issued By HC Wainwright - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 01, 2024
pulisher
Nov 01, 2024

Corcept’s relacorilant GRADIENT trial misses primary endpoint - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Corcept Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 01, 2024
pulisher
Oct 31, 2024

Earnings call: Corcept Therapeutics reports robust Q3 growth, raises guidance - Investing.com Canada

Oct 31, 2024
pulisher
Oct 31, 2024

Corcept Therapeutics Inc (CORT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Corcept Therapeutics Inc (CORT) Q3 2024 Earnings: EPS of $0.41 B - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

HC Wainwright Reiterates Buy Rating for Corcept Therapeutics (NASDAQ:CORT) - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Corcept Therapeutics (CORT) Tops Q3 Earnings and Revenue Estimates - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Corcept: Q3 Earnings Snapshot - Milford Mirror

Oct 31, 2024
pulisher
Oct 31, 2024

Corcept reports robust revenue growth in Q3 By Investing.com - Investing.com Canada

Oct 31, 2024
pulisher
Oct 31, 2024

abrdn plc Purchases 142,310 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Corcept Therapeutics Announces Third Quarter Financial Results, Positive Results From Phase 3 GRADIENT Trial in Patients With Cushing’s Syndrome and Provides Corporate Update - StockTitan

Oct 30, 2024
pulisher
Oct 29, 2024

Earnings Preview: Corcept Therapeutics - Benzinga

Oct 29, 2024
pulisher
Oct 26, 2024

Boston Trust Walden Corp Sells 69,924 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Oct 26, 2024
pulisher
Oct 24, 2024

Corcept Therapeutics (CORT) Set to Announce Earnings on Wednesday - MarketBeat

Oct 24, 2024
pulisher
Oct 23, 2024

Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call - Yahoo Finance

Oct 23, 2024
pulisher
Oct 23, 2024

Strength Seen in Corcept (CORT): Can Its 5.5% Jump Turn into More Strength? - MSN

Oct 23, 2024
pulisher
Oct 23, 2024

Zacks.com featured highlights Idaho Strategic, Qifu, Sezzle, Corcept and FinWise - Yahoo Finance

Oct 23, 2024
pulisher
Oct 21, 2024

Corcept stock stays a buy, with analyst eyeing validation of relacorilant’s cancer-fighting mechanism - Investing.com UK

Oct 21, 2024
pulisher
Oct 21, 2024

Analysts Set Corcept Therapeutics Incorporated (NASDAQ:CORT) PT at $65.25 - Defense World

Oct 21, 2024
pulisher
Oct 19, 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Position Reduced by Exchange Traded Concepts LLC - Defense World

Oct 19, 2024
pulisher
Oct 19, 2024

Exchange Traded Concepts LLC Decreases Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Oct 19, 2024
pulisher
Oct 18, 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Corcept Therapeutics (CORT) Stock Jumps Over 5% Amid Solid Finan - GuruFocus.com

Oct 18, 2024
pulisher
Oct 18, 2024

HC Wainwright Increases Corcept Therapeutics (NASDAQ:CORT) Price Target to $80.00 - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Corcept Therapeutics stock target raised, buy rating on Cushing's franchise growth - Investing.com Canada

Oct 18, 2024
pulisher
Oct 18, 2024

Key Takeaways From Corcept Therapeutics Analyst Ratings - Benzinga

Oct 18, 2024
pulisher
Oct 17, 2024

Corcept Therapeutics (NASDAQ:CORT) Sets New 12-Month HighHere's Why - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

Wall Street Analysts See a 43.01% Upside in Corcept (CORT): Can the Stock Really Move This High? - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

Corcept Therapeutics stock hits all-time high at $47.81 - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

Corcept Therapeutics stock hits all-time high at $47.81 By Investing.com - Investing.com UK

Oct 17, 2024
pulisher
Oct 17, 2024

Corcept (CORT) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance

Oct 17, 2024

코르셉트 테라퓨틱스 (CORT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):